FDA.reportPublic FDA data

Opana 40 MG 12 HR Extended Release Oral Tablet

RxCUI
977917
RxNorm name
Opana 40 MG 12 HR Extended Release Oral Tablet
Display name
Opana 40 MG 12 HR Extended Release Oral Tablet
Full name
Opana 40 MG 12 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5ca97412-1594-4a4e-b5e4-8593ffa1b242OPANA ER 40 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR oxymorphone hydrochloride 40 MG Extended Release Oral Tablet [Opana] [SBD] · 12 HR Opana 40 MG Extended Release Oral Tablet [SY] · Opana 40 MG 12 HR Extended Release Oral Tablet [SY]4220110715